These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29575453)

  • 1. Inhibition of α-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends.
    Shvadchak VV; Afitska K; Yushchenko DA
    Angew Chem Int Ed Engl; 2018 May; 57(20):5690-5694. PubMed ID: 29575453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells.
    Priss A; Afitska K; Galkin M; Yushchenko DA; Shvadchak VV
    J Med Chem; 2021 May; 64(10):6827-6837. PubMed ID: 33970620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein Dimers as Potent Inhibitors of Fibrillization.
    Kyriukha YA; Afitska K; Kurochka AS; Sachan S; Galkin M; Yushchenko DA; Shvadchak VV
    J Med Chem; 2019 Nov; 62(22):10342-10351. PubMed ID: 31625739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor.
    Afitska K; Priss A; Yushchenko DA; Shvadchak VV
    J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibril breaking accelerates α-synuclein fibrillization.
    Shvadchak VV; Claessens MM; Subramaniam V
    J Phys Chem B; 2015 Feb; 119(5):1912-8. PubMed ID: 25582977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Properties of Human α-Synuclein Related to Propensity to Amyloid Fibril Formation.
    Fujiwara S; Kono F; Matsuo T; Sugimoto Y; Matsumoto T; Narita A; Shibata K
    J Mol Biol; 2019 Aug; 431(17):3229-3245. PubMed ID: 31181290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-Induced Oligomers of α-Synuclein Inhibit Amyloid Fibril Growth and Show No Toxicity.
    Galkin M; Topcheva O; Priss A; Borisova T; Shvadchak VV
    ACS Chem Neurosci; 2023 Jun; 14(11):2027-2034. PubMed ID: 37162160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.
    Fujiwara S; Araki K; Matsuo T; Yagi H; Yamada T; Shibata K; Mochizuki H
    PLoS One; 2016; 11(4):e0151447. PubMed ID: 27097022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A RaPID Macrocyclic Peptide That Inhibits the Formation of α-Synuclein Amyloid Fibrils.
    Ikenoue T; Oono M; So M; Yamakado H; Arata T; Takahashi R; Kawata Y; Suga H
    Chembiochem; 2023 Jun; 24(12):e202300320. PubMed ID: 37186077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.
    Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y
    J Biol Chem; 2021; 296():100663. PubMed ID: 33862084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
    Lam HT; Graber MC; Gentry KA; Bieschke J
    Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation.
    Waudby CA; Knowles TP; Devlin GL; Skepper JN; Ecroyd H; Carver JA; Welland ME; Christodoulou J; Dobson CM; Meehan S
    Biophys J; 2010 Mar; 98(5):843-51. PubMed ID: 20197038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation.
    Hornedo-Ortega R; Cerezo AB; Troncoso AM; Garcia-Parrilla MC
    Food Chem Toxicol; 2018 Oct; 120():41-49. PubMed ID: 29964084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
    Watson MD; Lee JC
    Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation.
    Falke M; Victor J; Wördehoff MM; Peduzzo A; Zhang T; Schröder GF; Buell AK; Hoyer W; Etzkorn M
    Chem Phys Lipids; 2019 May; 220():57-65. PubMed ID: 30826264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naphthoquinone-dopamine hybrids disrupt α-synuclein fibrils by their intramolecular synergistic interactions with fibrils and display a better effect on fibril disruption.
    Zhou Y; Yao Y; Yang Z; Tang Y; Wei G
    Phys Chem Chem Phys; 2023 May; 25(20):14471-14483. PubMed ID: 37190853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.